Description
Furamag Capsules 50 mg. №30
Ingredients:
Each capsule contains 50 mg of furazidin.
Mechanism of Action:
Furazidin, the active ingredient in Furamag capsules, exerts its therapeutic effects by disrupting the synthesis of bacterial DNA, thereby inhibiting the growth and proliferation of susceptible bacteria in the urinary tract.
Pharmacological Properties:
Furazidin is a synthetic nitrofuran derivative with broad-spectrum antibacterial activity against various gram-negative and gram-positive bacteria commonly implicated in urinary tract infections.
Indications for Use:
Furamag capsules are indicated for the treatment of uncomplicated urinary tract infections caused by susceptible strains of bacteria, including Escherichia coli, Proteus mirabilis, and Staphylococcus saprophyticus.
Contraindications:
Do not use Furamag capsules if you have a known hypersensitivity to furazidin or other nitrofurans. Additionally, avoid Furamag in patients with severe renal impairment (creatinine clearance less than 30 mL/min).
Side Effects:
Common side effects of Furamag may include gastrointestinal disturbances (nausea, vomiting, diarrhea), allergic reactions (rash, itching), and rarely, peripheral neuropathy. Discontinue the medication and consult a healthcare professional if you experience any severe adverse reactions.
Usage Instructions:
The recommended dosage of Furamag is one 50 mg capsule taken orally three times a day with a full glass of water. It is essential to complete the full course of treatment as prescribed by your healthcare provider to ensure the eradication of the infection.
Benefits Compared to Analogues:
Furamag offers a favorable safety profile and high efficacy in the treatment of urinary tract infections, supported by clinical evidence demonstrating its potent antibacterial activity and tolerability. Compared to some other antibiotics, Furamag poses a lower risk of developing bacterial resistance.
Suitable Patient Groups:
Furamag is generally well-tolerated and can be used in various patient populations, including adults, elderly individuals, and children above the age of 6 years. However, specific dosing adjustments may be necessary in patients with renal impairment to prevent drug accumulation and toxicity.
Storage Conditions and Shelf Life:
Store Furamag capsules in a cool, dry place away from direct sunlight and moisture. Keep the medication out of reach of children. Check the expiration date on the packaging and do not use the capsules beyond the stated shelf life.
Packaging Description:
Furamag capsules are supplied in blister packs containing 30 capsules each. The packaging is designed to protect the capsules from environmental factors and maintain their stability and potency throughout the shelf life.
Clinical Evidence and Proven Effectiveness:
Furazidin, the active component of Furamag capsules, has been extensively studied for its efficacy in treating urinary tract infections. Clinical trials have consistently demonstrated the bactericidal effects of furazidin against common uropathogens, leading to successful outcomes in patients with uncomplicated UTIs.
